Zhejiang Medicine Co., Ltd. (SHA:600216)
China · Delayed Price · Currency is CNY 11.14
-0.14 (-1.24%)
Nov 6, 2026, 3:00 PM CST
Zhejiang Medicine Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3,169 | 3,167 | 1,966 | 1,460 | 1,438 | 1,769 |
Short-Term Investments | - | - | - | - | - | 2.9 |
Trading Asset Securities | 597.55 | 250.32 | 294.91 | 328.31 | 447.29 | 454.4 |
Cash & Short-Term Investments | 3,767 | 3,418 | 2,261 | 1,788 | 1,885 | 2,226 |
Cash Growth | 18.17% | 51.17% | 26.41% | -5.15% | -15.30% | 14.17% |
Accounts Receivable | 1,554 | 1,674 | 1,830 | 1,419 | 1,501 | 1,594 |
Other Receivables | 157.17 | 115.26 | 194.79 | 239.14 | 67.35 | 105.17 |
Receivables | 1,711 | 1,790 | 2,025 | 1,658 | 1,568 | 1,699 |
Inventory | 2,180 | 1,855 | 2,133 | 2,011 | 1,995 | 1,873 |
Prepaid Expenses | - | - | - | - | 0.03 | 0.36 |
Other Current Assets | 238.52 | 149.36 | 166.46 | 143.88 | 207.17 | 236.04 |
Total Current Assets | 7,897 | 7,211 | 6,585 | 5,601 | 5,655 | 6,035 |
Property, Plant & Equipment | 5,679 | 5,904 | 6,121 | 6,019 | 5,618 | 5,360 |
Long-Term Investments | 260.15 | 137.75 | 156.51 | 166.21 | 144.51 | 126.07 |
Goodwill | - | - | - | 18.68 | 27.91 | 36.03 |
Other Intangible Assets | 621.19 | 603.44 | 684.4 | 744.3 | 747.68 | 728.81 |
Long-Term Deferred Tax Assets | 121.17 | 125.43 | 124.94 | 82.12 | 77.41 | 78.8 |
Long-Term Deferred Charges | 8.62 | 8.77 | 12.81 | 6.22 | 8.85 | 0.41 |
Other Long-Term Assets | 151.45 | 99.68 | 110.66 | 141.15 | 153.27 | 167.76 |
Total Assets | 14,738 | 14,091 | 13,795 | 12,780 | 12,433 | 12,532 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 961.97 | 814.63 | 744.68 | 744.03 | 702.48 | 897.83 |
Accrued Expenses | 211.51 | 532.95 | 544.93 | 534.16 | 263.98 | 287.32 |
Short-Term Debt | 250.18 | 243.21 | 278.28 | 208.22 | 82.25 | 225.33 |
Current Portion of Long-Term Debt | 205.35 | 273.24 | 306.3 | 370.37 | 550.64 | - |
Current Portion of Leases | - | 0.34 | 0.56 | 0.3 | 0.28 | - |
Current Income Taxes Payable | 111.96 | 78.56 | 170.55 | 11.88 | 21.75 | 153.51 |
Current Unearned Revenue | 41.13 | 32 | 29.31 | 43.95 | 61.88 | 53.81 |
Other Current Liabilities | 417.3 | 464.85 | 494.84 | 565.52 | 782.11 | 1,407 |
Total Current Liabilities | 2,199 | 2,440 | 2,569 | 2,478 | 2,465 | 3,025 |
Long-Term Debt | 475.31 | 357.25 | 171.15 | 230.22 | 200.19 | 250.34 |
Long-Term Leases | 0.57 | 0.36 | 0.14 | 0.32 | 0.62 | 1.16 |
Long-Term Unearned Revenue | 116.41 | 130.5 | 104.6 | 84.16 | 54.11 | 53.08 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 2.47 | 21.12 |
Other Long-Term Liabilities | 67.72 | 73.7 | 82.2 | - | - | - |
Total Liabilities | 2,859 | 3,002 | 2,928 | 2,793 | 2,723 | 3,350 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 961.64 | 961.64 | 961.64 | 964.98 | 965.13 | 965.13 |
Additional Paid-In Capital | 2,031 | 1,871 | 1,988 | 2,005 | 1,941 | 1,692 |
Retained Earnings | 8,646 | 8,221 | 7,700 | 6,682 | 6,417 | 6,195 |
Treasury Stock | -142.16 | -125.49 | - | -27.63 | -57.69 | -59.98 |
Comprehensive Income & Other | -4.27 | 15.27 | -1.36 | 5.77 | -5.27 | -13.99 |
Total Common Equity | 11,492 | 10,943 | 10,648 | 9,631 | 9,260 | 8,779 |
Minority Interest | 387.43 | 145.69 | 219.8 | 355.68 | 449.98 | 402.93 |
Shareholders' Equity | 11,879 | 11,089 | 10,868 | 9,986 | 9,710 | 9,182 |
Total Liabilities & Equity | 14,738 | 14,091 | 13,795 | 12,780 | 12,433 | 12,532 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 931.41 | 874.41 | 756.43 | 809.44 | 833.97 | 476.82 |
Net Cash (Debt) | 2,835 | 2,543 | 1,504 | 978.89 | 1,051 | 1,749 |
Net Cash Growth | 26.90% | 69.06% | 53.67% | -6.90% | -39.89% | 75.16% |
Net Cash Per Share | 2.97 | 2.66 | 1.57 | 1.03 | 1.09 | 1.82 |
Filing Date Shares Outstanding | 970.35 | 947.91 | 961.64 | 902.84 | 958.3 | 958.3 |
Total Common Shares Outstanding | 970.35 | 947.91 | 961.64 | 902.84 | 958.3 | 958.3 |
Working Capital | 5,697 | 4,771 | 4,015 | 3,123 | 3,190 | 3,010 |
Book Value Per Share | 11.84 | 11.54 | 11.07 | 10.67 | 9.66 | 9.16 |
Tangible Book Value | 10,870 | 10,340 | 9,964 | 8,868 | 8,484 | 8,014 |
Tangible Book Value Per Share | 11.20 | 10.91 | 10.36 | 9.82 | 8.85 | 8.36 |
Buildings | - | 3,303 | 3,032 | 2,919 | 2,812 | 2,509 |
Machinery | - | 7,953 | 7,418 | 6,897 | 6,158 | 5,366 |
Construction In Progress | - | 627.3 | 982.5 | 931.69 | 825.71 | 1,119 |